Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Blackhawk Growth Corp C.BLR.WT


Primary Symbol: C.BLR Alternate Symbol(s):  BLRZF

Financial Services Asset Management
Blackhawk Growth Corp. is a Canada-based investment holding company. The Company invests in equity and debt instruments of companies to generate positive returns for shareholders. It focuses on investing in multiple companies across a variety of sectors across North America. The Company has focused its investments on the health, cannabis and cannabidiol (CBD) industries, in both Canada and the... see more

Recent & Breaking News (CSE:BLR)

Blackhawk Growth Announces Plan to Spin-Out Psychedelic Subsidiaries and Proposes 1:1 Distribution Ratio

TheNewsWire December 15, 2021

Blackhawk Growth Fully Funds Phase II Clinical Trials in Psychedelics and Begins Development of Digital Mental Health Treatments

TheNewsWire December 13, 2021

Blackhawk Growth to Complete Strategic Investment of Digital Mind Technology; Fully Funds Phase 1 Clinical Trial for Digital Mind and Phase 2 Clinical Trial for MindBio Therapeutics

TheNewsWire December 7, 2021

Blackhawk Growth Completes Investment in California-Based Licensed Distribution Center - TERP Wholesale, LLC, Company Generated CAD$3,902,888 Revenue in 2020

TheNewsWire December 1, 2021

Blackhawk Growth Files Quarter Ended September 30, 2021 Financials and Reports Increase in Value of its Portfolio by 165% Quarter Over Quarter

TheNewsWire November 29, 2021

Blackhawk Growth Enters into Credit Facility for up to $10 Million

TheNewsWire November 23, 2021

Blackhawk Growth's MindBio Therapeutics Advances Microdosing Clinical Trial to 59 Patients

TheNewsWire November 15, 2021

Blackhawk Growth's MindBio Therapeutics Completes Safety Milestone in its Phase 1 Clinical Trials

TheNewsWire November 8, 2021

Blackhawk Growth's MindBio Therapeutics Looks to Expand Microdosing Clinical Trials

TheNewsWire November 1, 2021

Blackhawk Growth Files Fiscal Year Ended June 30, 2021 Financial Reports

TheNewsWire October 29, 2021

Blackhawk Growth's Subsidiary MindBio Therapeutics Appoints Patrick Moher as Advisor

TheNewsWire October 28, 2021

Blackhawk Growth Appoints New Advisor to Support Expansion into Psychedelics And Mental Health Treatments

TheNewsWire October 14, 2021

Blackhawk Growth's SAC Pharma Continues to Expand Product Line and Services

TheNewsWire October 12, 2021

Blackhawk Growth's MindBio Therapeutics Brings Digital Mental Health Technology To Psychedelics Clinical Trials

TheNewsWire October 7, 2021

Blackhawk Growth's MindBio Therapeutics Successfully Progressed to the Second Half of their Phase 1 Microdosing Clinical Trial

TheNewsWire October 4, 2021

BLACKHAWK GROWTH'S MINDBIO THERAPEUTICS SIGNS COLLABORATION AGREEMENT WITH DIGITAL MIND TECHNOLOGY TECHNOLOGY

TheNewsWire September 29, 2021

Blackhawk's MindBio Therapeutics Utilizes Trip Pharma to Bring Microdosing Trials to North America

TheNewsWire September 23, 2021

Blackhawk Growth's MindBio Therapeutics Plans to Commercialize Intellectual Property Generated from the University of Auckland's Clinical Trial in Psychedelic Assisted Therapy in Advanced Stage Cancer Patients

TheNewsWire September 16, 2021

Blackhawk Growth's MindBio Therapeutics Opens World Class Facility for the Pharmaceutical Industry

TheNewsWire September 13, 2021

Blackhawk Growth's SAC Pharma Announces Record August Revenue of CDN$460,000 and Includes Operational Update

TheNewsWire September 9, 2021